SIOG – International Society of Geriatric Oncology shared on LinkedIn:
“For older adults with oesophageal or gastric cancer, function lost during neoadjuvant therapy or surgery is often hard to win back, and the decisions that protect it are spread across the whole MDT.
The Upper GI MDT at SIOG 2026 follows one complex case through the full pathway: recent advances in neoadjuvant therapy and the hidden risks for tolerance, how frailty and sarcopenia change surgical management, the nutritional interventions that should never be missed, and how to prevent functional decline and support recovery across treatment. The session moves stage by stage through the case and closes with open discussion, so it’s a case worth bringing back to your own tumour board.
